About: Henan Cancer Hospital

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Henan Cancer Hospital Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

hospital in Zhengzhou, Henan, China

Attributes	Values
rdf:type	Item
description	griya sakit (jv) rumah sakik (min) rumoh sakét (ace) rumah sakit di Republik Rakyat Tiongkok (id) চীনের হাসপাতাল (bn) مستشفى في تشنغتشو، الصين (ar) hospital in Zhengzhou, Henan, China (en) 中国河南省郑州市的三级甲等肿瘤专科医院 (zh)
rdfs:label	Henan Cancer Hospital (en) 河南省肿瘤医院 (zh)
skos:prefLabel	Henan Cancer Hospital (en) 河南省肿瘤医院 (zh)
name	Henan Cancer Hospital (en) 河南省肿瘤医院 (zh)
ROR ID	wds:Q11141679-F01ACC24-F122-4F7E-A159-9A4B130266CC
ROR ID	043ek5g31
instance of	wds:Q11141679-E881D02A-B1BD-4C8B-9BA9-284A93C732E2 wds:Q11141679-EACA271F-139E-443F-9917-60461134180B
instance of	hospital medical organization
country	wds:Q11141679-71A82DAA-9EAF-4EB6-AF47-E8A5D7F6506F
country	China
Google Knowledge Graph ID	wds:Q11141679-F2AFE85A-20CE-4208-BB80-410D8B2E494E
Ringgold ID	wds:Q11141679-9E99D183-9645-437E-9FD9-49BF28D31778
Google Knowledge Graph ID	http://g.co/kg/g/11_yxw_f0
Google Knowledge Graph ID	/g/11_yxw_f0
Ringgold ID	377327
inception	wds:Q11141679-0096B01F-0E61-4ED1-8E2A-BE5D7E7C4E05
inception	1977-01-01 00:00:00Z (xsd:dateTime)
Commons category	wds:Q11141679-199d4ed6-8993-4a87-9dcc-daf06555e30e
Commons category	Henan Cancer Hospital
skos:altLabel	河南省肿瘤研究所 (zh) 郑州大学附属肿瘤医院 (zh)
located in the adm...erritorial entity	wds:Q11141679-4D42217C-F940-4289-A5DD-F2FA1948060D
ISNI	wds:Q11141679-47F2BDB4-1FD8-4DED-9E79-54FEAC73EFB5
coordinate location	wds:Q11141679-21F2AC7B-AC27-4352-B39B-78BA951DB1F9
official website	wds:Q11141679-F2752E80-3843-4AB6-A079-CE883F83F406
located in the adm...erritorial entity	Zhengzhou
ISNI	0000000417994638
coordinate location	POINT(113.702005 34.771067)
official website	http://www.anti-cancer.com.cn/
GRID ID	wds:Q11141679-FDCBA120-173F-44D5-A2AD-45A425242B44
GRID ID	grid.414008.9
is owl:sameAs of	Henan Cancer Hospital
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q11141679 https://zh.wikipedia.org/wiki/%E6%B2%B3%E5%8D%97%E7%9C%81%E8%82%BF%E7%98%A4%E5%8C%BB%E9%99%A2 Category:Henan Cancer Hospital
is research site of	A Phase 3 Randomized, Double-blind, Placebo-controlled, Multicenter Trial of Maintenance Treatment With BGB-290 Versus Placebo in Patients With Platinum-sensitive Recurrent Ovarian Cancer Oral Paclitaxel Trial In Recurrent and Metastatic Breast Cancer As 1st Line Therapy A Study of Bemarituzumab (FPA144) Combined With Modified FOLFOX6 (mFOLFOX6) in Gastric/Gastroesophageal Junction Cancer (FIGHT) A Multi-Center Phase 2 Study to Evaluate Efficacy and Safety of Oral Abexinostat as Monotherapy in Patients With Relapsed or Refractory Follicular Lymphoma The Safety and Efficacy of CART-19 Cells in Relapse and Refractory Patients With CD19+ B-cell Lymphoma Anti-PD-1 in Combination With Chemotherapy as First-Line Treatment to Lung Cancer Study of Apatinib as the Maintenance Therapy in Advanced Lung Adenocarcinoma Association of Genetic Polymorphisms With Capecitabine-based Chemotherapy Toxicities in Chinese Solid Tumor Patients Efficacy of HIPEC in the Treatment of Locally Advanced Gastric Cancer After radIcal Gastrectomy With D2 A Study Comparing Obinutuzumab and BGB-3111 Versus Obinutuzumab Alone in Treating R/R Follicular Lymphoma Irinotecan Plus S1 Versus S1 in Patients With Previously Treated Advanced Esophageal Cancer: ESWN 01 Trial A Study of the Efficacy and Safety of Bevacizumab in Chinese Women With Newly Diagnosed, Previously Untreated Stage III or Stage IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer ICP-022 Versus Chlorambucil Combined With Rituximab in the Treatment of Untreated CLL/SLL TPM Regimen (Thalidomide, Prednisone and Methotrexate) in LGLL Rituximab,Zanubrutinib in Combination With Lenalidomide, Followed by Zanubrutinib or Lenalidomide Maintenance in Patients With Primary or Secondary CNS Lymphoma Comparing the Efficacy of Nab-PHP and TCbHP in Neoadjuvant Therapy for HER2 Positive Operable Breast Cancer, A Multicenter, Randomized, Phase III Clinical Trial Neoadjuvant Study of Pyrotinib and Trastuzumab Plus Docetaxel in Patients With HER2 Positive Breast Cancer A Study to Evaluate Clinical Characteristics of Lung Cancer in Patients With Surgeries and Adjuvant Therapies eXalt3: Study Comparing X-396 (Ensartinib) to Crizotinib in ALK Positive Non-Small Cell Lung Cancer (NSCLC) Patients CEOP/IVE/GDP Compared With CEOP as the First-line Therapy for Newly Diagnosed Adult Patients With PTCL Docetaxel + Plinabulin Compared to Docetaxel + Placebo in Patients With Advanced NSCLC A Study of ZL-2306 (Niraparib) as Maintenance Treatment Following First-line Chemotherapy in Patients With Advanced Ovarian Cancer A Observational Study to Compare Effectiveness and Safety of the Surgeries in Patients With Esophageal Cancer A Study to Explore Clinical Characteristics and Prognoses of N2 Patients With Non-small Cell Lung Cancer An Observational Study to Evaluate Lymph Metastases and Prognoses of the Patients With Esophageal Cancer CD19/20 Bispecific Nanobody-derived CAR-T Cells in B Cell Lymphoma A Study of Zanubrutinib (BGB-3111) Versus Ibrutinib in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia A Study To Evaluate the Efficacy and Safety Of Atezolizumab or Placebo in Combination With Neoadjuvant Doxorubicin + Cyclophosphamide Followed By Paclitaxel + Trastuzumab + Pertuzumab In Early Her2-Positive Breast Cancer An Open Label Study to Determine the Safety and Efficacy of Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for Injection in Adolescent and Adult Patients With Hemophilia A. Efficacy and Safety of BGB-3111 in Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Study of Anlotinib in Patients With Primary Malignant Bone Tumors A Study of Atezolizumab and Paclitaxel Versus Placebo and Paclitaxel in Participants With Previously Untreated Locally Advanced or Metastatic Triple Negative Breast Cancer (TNBC) A Study of RC48-ADC Administered Intravenously to Patients With HER2-Positive Metastatic Breast Cancer An Observational Study to Explore Clinical Characteristics of the Patients With T1 Non-small Cell Lung Cancer Phase 3 Study of BGB-A317 Versus Sorafenib in Patients With Unresectable HCC Endocrine Therapy With or Without Abemaciclib (LY2835219) Following Surgery in Participants With Breast Cancer Study of Etoposide in Treating Patients With Recurrent or Metastatic Breast Cancer Apatinib Plus SHR1210 in Advanced Mucosal Melanoma A Phase III Study of Nimotuzumab Plus Concurrent Chemoradiotherapy in Loco-regional Esophageal Squamous Cell Carcinoma A Efficacy and Safety Study of Anlotinib Hydrochloride Capsule Combined With Chemotherapy Versus Placebo Combined With Chemotherapy as First-line Treatment in Subjects With Advanced Non-squamous Cell Non-small Cell Lung Cancer R-CEOP-90/R-CEOP-70 Versus R-CHOP-50 in the Treatment of Diffuse Large B-cell Lymphoma and Follicular Lymphoma Grade 3B Study of the Efficacy, Safety and Pharmacokinetics of BGB-290 in Subjects With Advanced Solid Tumors Afatinib in NSCLC With HER2 Mutation Irinotecan Plus Thalidomide in Second Line Advanced Gastric Cancer A Real World Study of Apatinib in Treatment of Patients With Gastric Carcinoma STOPPER CHINA:With Tandem Microspheres in the Treatment of Localized Hepatocellular Carcinoma Is Video-assisted Thoracoscopic Lobectomy a Clinical Alternative for Surgically Resectable Pathologic N2 NSCLC Patients An Efficacy Study Comparing Brigatinib Versus Alectinib in Advanced Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer Participants Who Have Progressed on Crizotinib Clinical Trial for Registration of HPV Nucleic Acid Genotyping Assay Kit A Study of SI-B003, a PD-1/CTLA-4 Bispecific Antibody, in Patients With Advanced Solid Tumors Tislelizumab Monotherapy Versus Salvage Chemotherapy for Relapsed/Refractory Classical Hodgkin Lymphoma Clinical Trial of CNCT19 Cell Injection in the Treatment of Relapsed or Refractory Acute Lymphoblastic Leukemia

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software